Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.3870
-0.0129 (-3.23%)
May 29, 2026, 4:00 PM EDT - Market closed
Milestone Scientific Revenue
Milestone Scientific had revenue of $2.16M in the quarter ending March 31, 2026, a decrease of -3.15%. This brings the company's revenue in the last twelve months to $8.90M, up 3.37% year-over-year. In the year 2025, Milestone Scientific had annual revenue of $8.97M with 3.99% growth.
Revenue (ttm)
$8.90M
Revenue Growth
+3.37%
P/S Ratio
3.84
Revenue / Employee
$593,573
Employees
15
Market Cap
34.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.97M | 344.05K | 3.99% |
| Dec 31, 2024 | 8.63M | -1.20M | -12.19% |
| Dec 31, 2023 | 9.83M | 1.02M | 11.60% |
| Dec 31, 2022 | 8.81M | -1.50M | -14.54% |
| Dec 31, 2021 | 10.30M | 4.87M | 89.52% |
| Dec 31, 2020 | 5.44M | -2.94M | -35.07% |
| Dec 31, 2019 | 8.37M | -1.25M | -12.97% |
| Dec 31, 2018 | 9.62M | -1.66M | -14.71% |
| Dec 31, 2017 | 11.28M | 799.90K | 7.63% |
| Dec 31, 2016 | 10.48M | 990.43K | 10.43% |
| Dec 31, 2015 | 9.49M | -841.53K | -8.14% |
| Dec 31, 2014 | 10.33M | 321.70K | 3.21% |
| Dec 31, 2013 | 10.01M | 1.36M | 15.76% |
| Dec 31, 2012 | 8.65M | 270.15K | 3.22% |
| Dec 31, 2011 | 8.38M | -1.37M | -14.07% |
| Dec 31, 2010 | 9.75M | 1.20M | 14.05% |
| Dec 31, 2009 | 8.55M | 1.93M | 29.07% |
| Dec 31, 2008 | 6.62M | 233.10K | 3.65% |
| Dec 31, 2007 | 6.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 85.53M |
| Retractable Technologies | 37.15M |
| Precision Optics Corporation | 28.94M |
| Bionano Genomics | 28.74M |
| Jin Medical International | 20.69M |
| Nephros | 19.12M |
| Sharps Technology | 3.53M |
| Femasys | 2.38M |
MLSS News
- 3 days ago - Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures - GlobeNewsWire
- 16 days ago - Milestone Scientific Earnings Call Transcript: Q1 2026 - Transcripts
- 16 days ago - Milestone Scientific Quarterly report: Q1 2026 - Filings
- 16 days ago - Milestone Scientific Earnings release: Q1 2026 - Filings
- 16 days ago - Milestone Scientific reports Q1 EPS (1c), consensus (1c) - TheFly
- 16 days ago - Milestone Scientific backs FY26 revenue view $9.8M-$10.2M, consensus $9.91M - TheFly
- 16 days ago - Milestone Scientific Reports Financial Results for First Quarter 2026 - GlobeNewsWire
- 23 days ago - Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call - GlobeNewsWire